BMO Capital lowered the firm’s price target on Accenture to $375 from $385 and keeps a Market Perform rating on the shares after its Q2 results and updated guidance. The company’s quarter was “weak”, highlighted by the lower revenue growth range for FY24, the analyst tells investors in a research note. The size of the cut was meaningful, but its organic guidance was lowered by even more given higher M&A contribution, the firm added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN: